Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
saridegib oral (IPI 926 oral)
i
Other names:
IPI 926 oral
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Infinity Pharma, Mundipharma
Drug class:
Hedgehog cell-signalling pathway inhibitor, SMO protein inhibitor
Related drugs:
‹
vismodegib (14)
sonidegib (11)
GANT61 (2)
cyclopamine (2)
glasdegib (1)
GANT1 (1)
BMS-833923 (0)
GT1708F (0)
Oxy210 (0)
SUBA-itraconazole (0)
IPI-926 topical (0)
ENV 101 (0)
ZSP1602 (0)
vismodegib (14)
sonidegib (11)
GANT61 (2)
cyclopamine (2)
glasdegib (1)
GANT1 (1)
BMS-833923 (0)
GT1708F (0)
Oxy210 (0)
SUBA-itraconazole (0)
IPI-926 topical (0)
ENV 101 (0)
ZSP1602 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
PTCH1 deletion
Medulloblastoma
PTCH1 deletion
Medulloblastoma
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
SMO D473H
Medulloblastoma
SMO D473H
Medulloblastoma
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
IPI 926 oral
Sensitive: D – Preclinical
IPI 926 oral
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login